Wacker business figures 2025 - slight sales growth expected for 2026

Wacker Chemie AG has confirmed its preliminary results for fiscal 2025 and reported a decline in sales. The Group generated revenue of €5.49 billion, around four percent less than in the previous year. EBITDA amounted to €427 million and was thus significantly lower than in 2024. Before extraordinary expenses, the operating result reached €529 million. Lower sales volumes and prices, lower capacity utilization of production facilities and continued high energy costs in Germany had a particularly negative impact. Additional restructuring expenses and impairments led to a negative annual result of € -805 million. These included impairment losses on investments and write-downs in connection with previous acquisitions. The Executive Board and Supervisory Board therefore intend to propose to the Annual General Meeting that no dividend be distributed for the 2025 financial year. According to CEO Christian Hartel, the chemical industry continues to be characterized by weak demand, geopolitical uncertainties and increasing overcapacities.

Pace cost-cutting program at Wacker and cautious outlook

To strengthen its competitiveness, Wacker launched the Pace cost-cutting program in October 2025. The aim is to reduce annual production and administration costs by more than €300 million. Over 1,500 jobs are to be cut worldwide as part of the program. At the same time, the Group is focusing its business model more strongly on specialty chemicals, semiconductor polysilicon and biotechnology. The company expects sales growth in the low single-digit percentage range for 2026. EBITDA is expected to be between € 550 million and € 700 million. While the solar polysilicon business remains difficult, Wacker sees growth potential particularly in high-purity polysilicon for the semiconductor industry and in selected specialty chemicals segments. Efficiency measures and cost savings should also help stabilize earnings.